Global Cord Blood Corp Asset Turnover Ratio (CO), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Global Cord Blood Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Global Cord Blood Corp asset turnover ratio, the ability of Global Cord Blood Corp's assets to generate revenue in the fourth quarter 2022, increased sequentially to 0.16 in the fourth quarter (Mar 31 2022), yet the ratio remained below the average, as CO's position remain challenging.

Within sector 12 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2022 compared to previous quarter at no. 1306.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CO Asset Turnover Ratio (Mar 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2021)
IV. Quarter
Y / Y Asset Change 18.35 % 16.64 % 18.35 % 19.27 % 4.46 %
Y / Y Revenue Change 10.8 % - - - 2.6 %
Asset Turnover Ratio (TTM) 0.16 - - - 0.22
CO's Total Ranking # 1306 # 1306 # 0 # 1307 # 0
Seq. Asset Change -5.26 % 5.55 % 0.83 % 17.37 % -6.63 %
Seq. Revenue Change - - - - 265.08 %



Asset Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 13
Healthcare Sector # 133
Overall Market # 1306

Asset Turnover Ratio Statistics
High Average Low
11.72 8.77 5.28
(Mar 31 2020)   (Mar 31 2016)




CO Company Profile • Back to CO Efficiency Comparisons • Compare CO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2022 Assets at quarter ending Mar 31 2022
Livanova Plc  0.45 $ 1,027.937  Millions$ 2,304.441  Millions
Standard Biotools Inc   0.44 $ 124.291  Millions$ 279.664  Millions
Coherus Oncology inc   0.44 $ 303.632  Millions$ 688.497  Millions
Horizon Therapeutics Public Limited Company  0.44 $ 3,769.249  Millions$ 8,558.543  Millions
T2 Biosystems Inc   0.44 $ 28.336  Millions$ 64.628  Millions
Steris Plc  0.44 $ 4,585.064  Millions$ 10,462.880  Millions
Seagen Inc   0.44 $ 1,668.848  Millions$ 3,816.583  Millions
China Pharma Holdings Inc  0.43 $ 8.888  Millions$ 20.455  Millions
Heska Corporation  0.43 $ 258.036  Millions$ 595.576  Millions
Bristol myers Squibb Company  0.43 $ 46,960.000  Millions$ 108,509.500  Millions
American Shared Hospital Services  0.43 $ 19.309  Millions$ 44.704  Millions
Amgen Inc   0.43 $ 26,316.000  Millions$ 61,281.750  Millions
Innoviva Inc   0.43 $ 396.407  Millions$ 927.565  Millions
Anika Therapeutics Inc   0.43 $ 150.195  Millions$ 351.459  Millions
Utah Medical Products Inc  0.43 $ 50.413  Millions$ 117.996  Millions
Xencor Inc  0.42 $ 326.641  Millions$ 772.250  Millions
Halozyme Therapeutics Inc   0.42 $ 471.567  Millions$ 1,119.490  Millions
Inotiv Inc   0.42 $ 277.493  Millions$ 660.476  Millions
Seres Therapeutics Inc   0.42 $ 140.702  Millions$ 335.172  Millions
Aytu Biopharma Inc  0.42 $ 92.703  Millions$ 221.512  Millions
Integra Lifesciences Holdings Corp  0.42 $ 1,559.015  Millions$ 3,735.408  Millions
Sonendo Inc   0.42 $ 34.803  Millions$ 83.483  Millions
Nabriva Therapeutics Plc  0.42 $ 34.386  Millions$ 82.805  Millions
Gilead Sciences Inc   0.41 $ 27,472.000  Millions$ 66,528.500  Millions
Sientra Inc   0.41 $ 78.845  Millions$ 192.240  Millions
Cumberland Pharmaceuticals Inc   0.41 $ 36.623  Millions$ 89.395  Millions
Brookdale Senior Living Inc   0.41 $ 2,639.677  Millions$ 6,490.682  Millions
Teleflex Incorporated  0.40 $ 2,817.353  Millions$ 6,962.845  Millions
Neuronetics Inc   0.40 $ 57.045  Millions$ 141.636  Millions
Ispecimen inc   0.40 $ 10.690  Millions$ 26.559  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.